Company: NCEL
Filing Date: 2025-05-16
Form Type: 20-F
Source: 0001213900-25-044868
Chunk: 251

Company: NewcelX Ltd.
Filing Date: 2025-05-16
Form: 20-F
Item: Item 4
Chunk 251
---
 pre-funded warrants. As of December 31, 2024, we had $1,665,395 in cash and cash equivalents.

The table below summarizes
our cash flows for the years ended December 31, 2024 and 2023:

                                                            2024                      2023                  
  Net cash used in operating activities                     $         (4,267,884      $         (9,684,466  
  Net cash used in investing activities                                   (3,917                         -  
 ────────────────────────────────────────────────────────────────────────────────────────────────────────────
  Net cash provided by financing activities                 $          5,039,516      $          1,633,746  
  Net increase (decrease) in cash and cash equivalents      $            767,715      $         (8,050,720  

Operating
Activities

Net cash used in operating
activities was $4,267,884 during the year ended December 31, 2024 compared with net cash used in operating activities of $9,684,466 for
the year ended December 31, 2023. The change in cash used in operating activities for the year ended December 31, 2024 was due to our
reporting a net loss of $1,980,810 for the year ended December 31, 2024, compared with a net loss of $12,172,029 for the same period in
2023, driven mainly by a $7,426,950 decrease in total operating costs and a $2,499,969 increase in Other income due to the termination
of EF Licensing Agreement for the year ended December 31, 2024.

Until
we can generate significant recurring revenues, we expect to satisfy our future cash needs through debt and/or equity financings. We
cannot be certain that additional funding will be available to us on acceptable terms, if at all. This may raise substantial doubt about
our ability to continue as a going concern. The financial statements do not include any adjustments that might result from the outcome
of this uncertainty. If funds are not available, we may be required to delay, reduce the scope of, or eliminate research or development
plans for, or commercialization efforts with respect to our product candidates.

Investing
Activities

For the year ended December
31, 2024, net cash used in investing activities was $3,917 related to purchases of property and equipment.

Financing
Activities

Net
cash